WD-1602
- Generic Name
- WD-1602
A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Hong Kong WD Pharmaceutical Co., Limited
- Target Recruit Count
- 20
- Registration Number
- NCT04592822
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath